Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Performance Evaluation of the BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

NCT05557422 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT05557422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05557422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Performance Evaluation of the BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.
Lead sponsor
Becton, Dickinson and Company
Phase
Observational
Overall status
Completed
Start date
October 12, 2022
Completion date
May 8, 2024
Enrollment
322 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphoproliferative diseases (clpd)